These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 14504045)

  • 21. [The role of bisphosphonates of adjuvant therapy in breast cancer].
    Gálvez-Muñoz E; Rodríguez-Lescure Á
    Med Clin (Barc); 2010 Jun; 135(2):70-4. PubMed ID: 20022069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antitumor potential of bisphosphonates.
    Clézardin P
    Semin Oncol; 2002 Dec; 29(6 Suppl 21):33-42. PubMed ID: 12584693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [From laundry product to cancer drug--history of a drug class].
    Possinger K
    Med Klin (Munich); 2000 Oct; 95 Suppl 2():3-7. PubMed ID: 11089381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities.
    Santini D; Fratto ME; Vincenzi B; La Cesa A; Dianzani C; Tonini G
    BioDrugs; 2004; 18(4):269-78. PubMed ID: 15244502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bisphosphonates--mechanisms of action in multiple myeloma.
    Shipman CM; Rogers MJ; Vanderkerken K; Van Camp B; Graham R; Russell G; Croucher PI
    Acta Oncol; 2000; 39(7):829-35. PubMed ID: 11145441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diphosphonates--pharmacology and clinical use].
    Aaseth J; Syversen U; Førre O
    Tidsskr Nor Laegeforen; 1998 Mar; 118(7):1064-6. PubMed ID: 9531831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL.
    Ohba T; Cole HA; Cates JM; Slosky DA; Haro H; Ando T; Schwartz HS; Schoenecker JG
    J Bone Miner Res; 2014 Jun; 29(6):1431-45. PubMed ID: 24443409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential anticancer properties of bisphosphonates.
    Neville-Webbe HL; Gnant M; Coleman RE
    Semin Oncol; 2010 Jun; 37 Suppl 1():S53-65. PubMed ID: 20682373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bisphosphonates in the treatment of multiple myeloma].
    Stajszczyk M
    Przegl Lek; 2002; 59(1):37-42. PubMed ID: 12108045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphosphonates as treatment of bone metastases.
    Holen I; Coleman RE
    Curr Pharm Des; 2010; 16(11):1262-71. PubMed ID: 20166976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of bisphosphonates in cancer patients.
    Body JJ; Coleman RE; Piccart M
    Cancer Treat Rev; 1996 Jul; 22(4):265-87. PubMed ID: 9025784
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical value of bisphosphonates in cancer therapy.
    Lüftner D; Henschke P; Possinger K
    Anticancer Res; 2007; 27(4A):1759-68. PubMed ID: 17649770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of bisphosphonate effects on osteoclasts, tumor cell growth, and metastasis.
    Green JR; Clézardin P
    Am J Clin Oncol; 2002 Dec; 25(6 Suppl 1):S3-9. PubMed ID: 12562045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis].
    Chapurlat R; Meunier PJ
    Rev Chir Orthop Reparatrice Appar Mot; 1998 Nov; 84(8):743-51. PubMed ID: 10192126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct effects of bisphosphonates on breast cancer cells.
    Senaratne SG; Colston KW
    Breast Cancer Res; 2002; 4(1):18-23. PubMed ID: 11879555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bisphosphonates: preclinical aspects and use in osteoporosis.
    Fleisch HA
    Ann Med; 1997 Feb; 29(1):55-62. PubMed ID: 9073324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Last generation of amino-bisphosphonates (N-BPs) and cancer angio-genesis: a new role for these drugs?
    Santini D; Schiavon G; Angeletti S; Vincenzi B; Gasparro S; Grilli C; La Cesa A; Virzí V; Leoni V; Budillon A; Addeo SR; Caraglia M; Dicuonzo G; Tonini G
    Recent Pat Anticancer Drug Discov; 2006 Nov; 1(3):383-96. PubMed ID: 18221048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The crossover of bisphosphonates to cancer therapy.
    Sun M; Iqbal J; Singh S; Sun L; Zaidi M
    Ann N Y Acad Sci; 2010 Nov; 1211():107-12. PubMed ID: 21062299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aetiology of bone disease and the role of bisphosphonates in multiple myeloma.
    Ashcroft AJ; Davies FE; Morgan GJ
    Lancet Oncol; 2003 May; 4(5):284-92. PubMed ID: 12732166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.